Bullous pemphigoid and pemphigus vulgaris
- 8 June 2017
- Vol. 357, j2169
- https://doi.org/10.1136/bmj.j2169
Abstract
### What you need to know Autoimmune bullous diseases are characterised by blistering of the skin or mucous membranes.1 Blisters form due to the antibodies against structural skin components. The two most common bullous diseases are bullous pemphigoid and pemphigus vulgaris. Most of our epidemiological data comes from European studies. Estimates of the incidence of bullous pemphigoid range from 2.8 per 100 000 person years in the US2 to 4.28 per 100 000 person years in the UK3 most commonly presenting in people over 80 years old. Pemphigus vulgaris is rarer and its geographic distribution more variable: whereas in Israel the incidence has been estimated at 5.3 per 100 000 person years, in the UK it was only 0.7.4 To the generalist these may seem to be niche diseases and are often overlooked or misdiagnosed, leading to poor patient outcomes. Because of their chronic nature, high morbidity and mortality, and the systemic effects from treatment, affected people require intensive management. In the past few decades great strides have been made in understanding these diseases but and the development of novel treatments, however these treatments themselves are associated with substantial disease burden. This article highlights the pathophysiology, investigations, and management of bullous pemphigoid and pemphigus vulgaris. The aetiology of bullous pemphigoid and pemphigus vulgaris is poorly understood. Possible triggers for bullous pemphigoid include trauma as …This publication has 25 references indexed in Scilit:
- Incidence of bullous pemphigoid and mortality of patients with bullous pemphigoid in Olmsted County, Minnesota, 1960 through 2009Journal of the American Academy of Dermatology, 2014
- Diagnosis and classification of autoimmune blistering diseasesAutoimmunity Reviews, 2014
- Risk Factors for Bullous Pemphigoid in the Elderly: A Prospective Case–Control StudyJournal of Investigative Dermatology, 2011
- Modern diagnosis of autoimmune blistering skin diseasesAutoimmunity Reviews, 2010
- Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort studyBMJ, 2008
- Enzyme‐linked immunosorbent assay using multimers of the 16th non‐collagenous domain of the BP180 antigen for sensitive and specific detection of pemphigoid autoantibodiesExperimental Dermatology, 2007
- Pemphigus, Bullous Impetigo, and the Staphylococcal Scalded-Skin SyndromeNew England Journal of Medicine, 2006
- Mechanisms of blister induction by autoantibodiesExperimental Dermatology, 2005
- Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patientsBritish Journal of Dermatology, 2004
- Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris.Proceedings of the National Academy of Sciences of the United States of America, 1990